These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Statistical power in partially nested designs probing multilevel mediation. Kelcey B; Bai F; Xie Y Psychother Res; 2020 Nov; 30(8):1061-1074. PubMed ID: 32036780 [No Abstract] [Full Text] [Related]
4. Experimental Power for Indirect Effects in Group-randomized Studies with Group-level Mediators. Kelcey B; Dong N; Spybrook J; Shen Z Multivariate Behav Res; 2017; 52(6):699-719. PubMed ID: 28967790 [TBL] [Abstract][Full Text] [Related]
5. Required sample size to detect mediation in 3-level implementation studies. Williams NJ; Preacher KJ; Allison PD; Mandell DS; Marcus SC Implement Sci; 2022 Oct; 17(1):66. PubMed ID: 36183090 [TBL] [Abstract][Full Text] [Related]
6. Clinical trials with mechanism evaluation of intervention(s): mind the power and sample size calculation. Lee KM; Hellier J; Emsley R Trials; 2024 Aug; 25(1):527. PubMed ID: 39107853 [TBL] [Abstract][Full Text] [Related]
7. Generalized sample size determination formulas for experimental research with hierarchical data. Usami S Behav Res Methods; 2014 Jun; 46(2):346-56. PubMed ID: 24197710 [TBL] [Abstract][Full Text] [Related]
8. Sample size determinations for stepped-wedge clinical trials from a three-level data hierarchy perspective. Heo M; Kim N; Rinke ML; Wylie-Rosett J Stat Methods Med Res; 2018 Feb; 27(2):480-489. PubMed ID: 26988927 [TBL] [Abstract][Full Text] [Related]
9. Cost-efficient designs for three-arm trials with treatment delivered by health professionals: Sample sizes for a combination of nested and crossed designs. Moerbeek M Clin Trials; 2018 Apr; 15(2):169-177. PubMed ID: 29316807 [TBL] [Abstract][Full Text] [Related]
10. Sample size determination for three-level randomized clinical trials with randomization at the first or second level. Fazzari MJ; Kim MY; Heo M J Biopharm Stat; 2014; 24(3):579-99. PubMed ID: 24697506 [TBL] [Abstract][Full Text] [Related]
11. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
12. Multilevel mediation analysis: The effects of omitted variables in the 1-1-1 model. Tofighi D; West SG; MacKinnon DP Br J Math Stat Psychol; 2013 May; 66(2):290-307. PubMed ID: 22594884 [TBL] [Abstract][Full Text] [Related]
13. Sample size determination for mediation analysis of longitudinal data. Pan H; Liu S; Miao D; Yuan Y BMC Med Res Methodol; 2018 Mar; 18(1):32. PubMed ID: 29580203 [TBL] [Abstract][Full Text] [Related]
14. Statistical power analysis and sample size planning for moderated mediation models. Xu Z; Gao F; Fa A; Qu W; Zhang Z Behav Res Methods; 2024 Sep; 56(6):6130-6149. PubMed ID: 38308148 [TBL] [Abstract][Full Text] [Related]
15. Sample size and power calculations for causal mediation analysis: A Tutorial and Shiny App. Qin X Behav Res Methods; 2024 Mar; 56(3):1738-1769. PubMed ID: 37231326 [TBL] [Abstract][Full Text] [Related]
16. Design and analysis of non-pharmacological treatment trials with multiple therapists per patient. Roberts C; Walwyn R Stat Med; 2013 Jan; 32(1):81-98. PubMed ID: 22865729 [TBL] [Abstract][Full Text] [Related]
17. Selecting a Within- or Between-Subject Design for Mediation: Validity, Causality, and Statistical Power. Montoya AK Multivariate Behav Res; 2023; 58(3):616-636. PubMed ID: 35679239 [TBL] [Abstract][Full Text] [Related]
18. Impact of subject attrition on sample size determinations for longitudinal cluster randomized clinical trials. Heo M J Biopharm Stat; 2014; 24(3):507-22. PubMed ID: 24697555 [TBL] [Abstract][Full Text] [Related]
19. Three-Level Longitudinal Mediation with Nested Units: How does an Upper-Level Predictor Influence a Lower-Level Outcome via an Upper-Level Mediator Over Time? Zhang Q; Phillips B Multivariate Behav Res; 2018; 53(5):655-675. PubMed ID: 29985670 [TBL] [Abstract][Full Text] [Related]
20. Cluster randomized trials with a small number of clusters: which analyses should be used? Leyrat C; Morgan KE; Leurent B; Kahan BC Int J Epidemiol; 2018 Feb; 47(1):321-331. PubMed ID: 29025158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]